ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 109 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |